Bifunctional molecules targeting SARS-CoV-2 spike and the polymeric Ig receptor display neutralization activity and mucosal enrichment
The global health crisis and economic tolls of COVID-19 necessitate a panoply of strategies to treat SARS-CoV-2 infection. To date, few treatment options exist, although neutralizing antibodies against the spike glycoprotein have proven to be effective. Because infection is initiated at the mucosa a...
Saved in:
Main Authors: | Ian White (Author), Ninkka Tamot (Author), Rajitha Doddareddy (Author), Jason Ho (Author), Qun Jiao (Author), Paul B. Harvilla (Author), Tong-Yuan Yang (Author), Brian Geist (Author), M. Jack Borrok (Author), Matthew D. Truppo (Author), Rajkumar Ganesan (Author), Partha Chowdhury (Author), Adam Zwolak (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discovery and characterization of single-domain antibodies for polymeric Ig receptor-mediated mucosal delivery of biologics
by: Bharathikumar Vellalore Maruthachalam, et al.
Published: (2020) -
Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variants
by: Taichi Kuramochi, et al.
Published: (2022) -
Bispecific VH/Fab antibodies targeting neutralizing and non-neutralizing Spike epitopes demonstrate enhanced potency against SARS-CoV-2
by: Shion A. Lim, et al.
Published: (2021) -
HIV Entry and Its Inhibition by Bifunctional Antiviral Proteins
by: Alexander Falkenhagen, et al.
Published: (2018) -
Bifunctional antibiotic hybrids: A review of clinical candidates
by: Augustine Jing Jie Koh, et al.
Published: (2023)